Keros Therapeutics, Inc. (KROS)
NASDAQ·Healthcare·Biotechnology
$10.01
-0.65%
Mkt Cap $321.90M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$102.60
Range $96.00 – $107.00
Implied Upside
+925.5%
Consensus $102.60 vs current $10.01
NASDAQ·Healthcare·Biotechnology
$10.01
-0.65%
Mkt Cap $321.90M
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$102.60
Range $96.00 – $107.00
+925.5%
Consensus $102.60 vs current $10.01